Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Michael Tuttle

Showing results (101-110 of 320) with videos related to

Pageof 32
Sort By:
Molecular Imaging and Radionuclide Therapy|January 25, 2017
Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid CancerSteven M Larson, Joseph R Osborne, Ravinder K Grewal, et al.
Clinical Endocrinology|October 19, 2011
Iatrogenic hyperthyroidism does not promote weight loss or prevent ageing-related increases in body mass in thyroid cancer survivorsHanah N Polotsky, Matvey Brokhin, Gal Omry, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2013
Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systemsFabián Pitoia, Fernanda Bueno, Carolina Urciuoli, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2020
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted TherapiesTiffany Yeh, Michele Yeung, Eric J Sherman, et al.
Thyroid : Official Journal of the American Thyroid Association|June 11, 2013
Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 casesRonald Ghossein, Ian Ganly, Agnese Biagini, et al.
European Thyroid Journal|June 15, 2017
Patients with Multifocal Macroscopic Papillary Thyroid Carcinoma Have a Low Risk of Recurrence at Early Follow-Up after Total Thyroidectomy and Radioactive Iodine TreatmentAmanda La Greca, Bin Xu, Ronald Ghossein, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 16, 2013
Complete blood counts are frequently abnormal 1 year after dosimetry-guided radioactive iodine therapy for metastatic thyroid cancerRosalia P Padovani, R Michael Tuttle, Ravinder Grewal, et al.
Thyroid : Official Journal of the American Thyroid Association|August 4, 2011
Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progressionGeneviève Rondeau, Stephanie Fish, Lucy E Hann, et al.
The Journal of Clinical Endocrinology and Metabolism|October 7, 2025
Comparable Outcomes of Differentiated Thyroid Cancer in Immunocompromised versus Immunocompetent PatientsAmit Ritter, Alana Eagan, Helena Levyn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 28, 2015
Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET StudyJames Nagarajah, Alan L Ho, R Michael Tuttle, et al.
Pageof 32

Showing results (101-110 of 320) with videos related to

Sort By:
Pageof 32
Molecular Imaging and Radionuclide Therapy|January 25, 2017
Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid CancerSteven M Larson, Joseph R Osborne, Ravinder K Grewal, et al.
Clinical Endocrinology|October 19, 2011
Iatrogenic hyperthyroidism does not promote weight loss or prevent ageing-related increases in body mass in thyroid cancer survivorsHanah N Polotsky, Matvey Brokhin, Gal Omry, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2013
Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systemsFabián Pitoia, Fernanda Bueno, Carolina Urciuoli, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2020
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted TherapiesTiffany Yeh, Michele Yeung, Eric J Sherman, et al.
Thyroid : Official Journal of the American Thyroid Association|June 11, 2013
Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 casesRonald Ghossein, Ian Ganly, Agnese Biagini, et al.
European Thyroid Journal|June 15, 2017
Patients with Multifocal Macroscopic Papillary Thyroid Carcinoma Have a Low Risk of Recurrence at Early Follow-Up after Total Thyroidectomy and Radioactive Iodine TreatmentAmanda La Greca, Bin Xu, Ronald Ghossein, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 16, 2013
Complete blood counts are frequently abnormal 1 year after dosimetry-guided radioactive iodine therapy for metastatic thyroid cancerRosalia P Padovani, R Michael Tuttle, Ravinder Grewal, et al.
Thyroid : Official Journal of the American Thyroid Association|August 4, 2011
Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progressionGeneviève Rondeau, Stephanie Fish, Lucy E Hann, et al.
The Journal of Clinical Endocrinology and Metabolism|October 7, 2025
Comparable Outcomes of Differentiated Thyroid Cancer in Immunocompromised versus Immunocompetent PatientsAmit Ritter, Alana Eagan, Helena Levyn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 28, 2015
Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients: An ¹⁸F-FDG PET StudyJames Nagarajah, Alan L Ho, R Michael Tuttle, et al.
Pageof 32